196
Participants
Start Date
April 1, 2022
Primary Completion Date
April 30, 2025
Study Completion Date
May 7, 2025
Saroglitazar Magnesium 1 mg
Subjects randomized to Saroglitazar Magnesium 1 mg arm will receive Saroglitazar Magnesium 1 mg treatment for the entire treatment period up to Week 52.
Saroglitazar Magnesium 2 mg
Subjects randomized to Saroglitazar Magnesium 2 mg arm are switched to Saroglitazar Magnesium 1 mg treatment up to Week 52
Placebo
Subjects randomized to placebo arm will receive placebo treatment for the entire treatment period up to Week 52.
Zydus US038, Manhasset
Zydus US035, Rochester
Zydus TR005, Bursa
Zydus US015, Philadelphia
Zydus US016, Charlottesville
Zydus US039, Richmond
Zydus US041, Newport News
Zydus TR008, Gaziantep
Zydus US002, Charlotte
Zydus US020, Marietta
Zydus US027, Jacksonville
Zydus TR006, Mersin
Zydus US005, Miami
Zydus US019, Tampa
Zydus TR009, Istanbul
Zydus TR010, Istanbul
Zydus US006, Lakewood Rch
Zydus US028, Sarasota
Zydus TR003, Istanbul
Zydus TR001, Istanbul
Zydus TR002, Izmir
Zydus TR013, Izmir
Zydus US007, Birmingham
Zydus TR015, Melikgazi
Zydus TR011, Kocaeli
Zydus US014, Cincinnati
Zydus US001, Indianapolis
Zydus US034, Iowa City
Zydus US023, Rochester
Zydus US030, St Louis
Zydus US024, Omaha
Zydus US036, Marrero
Zydus US004, Houston
Zydus US042, Houston
Zydus US022, Aurora
Zydus US031, Murray
Zydus US021, Tucson
Zydus US013, Los Angeles
Zydus US011, Pasadena
Zydus US043, Sacramento
Zydus US033, Seattle
Zydus US037, New Haven
Zydus AR004, Buenos Aires
Zydus AR009, Buenos Aires
Zydus AR001, Buenos Aires
Zydus AR005, Buenos Aires
Zydus AR013, Buenos Aires
Zydus AR007, Buenos Aires
Zydus AR006, Buenos Aires
Zydus AR012, Buenos Aires
Zydus AR003, Buenos Aires
Zydus AR010, Santa Fe
Zydus IS001, Reykjavik
Zydus TR014, Adana
Zydus TR016, Altındağ
Zydus TR004, Ankara
Zydus TR017, Cebeli
Zydus Therapeutics Inc.
INDUSTRY